Infinity PharmaceuticalsINFIQ
13F holders, Q3 2025 (September 30)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Infinity Pharmaceuticals Inc. (INFIQ) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 0 sold out. The largest holder was Hantz Financial Services, Inc. ($0).
- Company
- Infinity Pharmaceuticals Inc.
- CUSIP
- 45665G303
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q3 2025: 500 shares bought, net +500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Hantz Financial Services, Inc. | 0.00% | New | 500 | $0 |
"% of holder's portfolio" is INFIQ's weight in each manager's 13F, not the share of Infinity Pharmaceuticals Inc. the manager owns.